Skip to content
Symphogen logo

Postdoc Scientist focused on In Silico Predictive Methods for Antibody Purification

Symphogen · Pharma & life sciences

Summary

This Postdoctoral Scientist role focuses on developing and implementing in silico predictive methods for antibody purification within a pharmaceutical setting. The position aims to create a digital framework for guiding purification strategies for complex antibody formats, reducing trial-and-error experiments and accelerating workflows.

Key facts

Status
Available· 19 days ago
Location
Ballerup
Contract duration
18 months
Work arrangement
On-site
Level
Entry
Education
Master's
Required skills
  • in silico predictive methods
  • antibody purification
  • chromatographic datasets
  • sequence-based purification modeling
  • bispecifics
  • aggregates
Benefits
  • possibility of extension
Pay (estimated, unofficial)
~kr. 510k–614k/yrRough guide for a full-time post; the employer named no amount How is this calculated?

Full description

Join Servier Symphogen as a Postdoc Scientist to pioneer in silico predictive methods for antibody purification and implementation in established purification workflows.

This 18-month Postdoctoral Scientist appointment, which includes the possibility of extension, represents a unique opportunity to gain experience in an established pharmaceutical setting. The cross‑functional nature of the role serves as excellent preparation for future professional advancement in industry.

You will evaluate and establish in silico methods to guide antibody purification strategies based on protein sequences, refining these in silico procedures for integration into existing purification workflows to increase efficiency.

You will join the Purification team within Drug Substance Development at Servier Symphogen and work closely with colleagues from Drug Substance Development, as well as from Research and Analytical teams.

The project aims to develop a digital framework for guiding purification strategies for complex antibody formats, including bispecifics and other high‑complexity modalities.

It addresses the challenge of product‑related impurities, such as mispaired species and aggregates, by limiting the number of trial‑and‑error experiments.

By integrating in silico tool evaluation with wet‑lab chromatographic datasets, the project aims to identify correlations to enable sequence‑based purification modeling.

Ultimately, this approach standardises and accelerates current purification workflows, ensuring complex antibody formats reach patients with efficiency and consistently high quality.

Apply on the company site